Letters by company

UNITED THERAPEUTICS Corp

2 letters discussing UTHR. Everything written about it on this site is on its ticker page.

Laughing Water Capital H1 2026 Laughing Water Capital sold through takeouts of Theravance Biopharma, Avanos Medical and SECURE Waste Infrastructure, leaving cash and merger securities for new opportunities. The portfolio added AnaptysBio ahead of its licensing dispute with GSK, while retaining conviction in Liquidia, NextNav, Lifecore Biomedical and Stride despite company-specific overhangs. H1 2026 +33.6% ANAB $1.7BAVNS $1.2BGSK $105BLFCR $172M
Polaris Capital Management First Quarter 2026 Global Equity Composite Commentary Polaris Global Equity Composite benefited from energy, technology, materials and utilities as the Strait of Hormuz closure reshaped sector leadership. The portfolio exited Methanex, Sally Beauty, UnitedHealth and Capgemini, then initiated Eastman Chemical and Ryanair on valuation, cost-cutting and supply-demand catalysts. FIRST QUARTER 2026 +5.9% CAPMF $22BDNBBF $48BE $86BMEOH $4.5B